TSX-V: STUD
Last: 0.03
Change: 0
Vol: 2,705,792
OTCQB: STLNF
Last: 0.02
Change: -0.00015
Vol: 69,344

News Releases

Stallion Uranium Announces Closing of Listed Issuer Financing Exemption (LIFE) Non-Brokered Private Placement

Vancouver, British Columbia, February 08, 2024 – Stallion Uranium Corp. (the "Company" or "Stallion") (TSX-V: STUD; OTCQB: STLNF; FSE: HM40) is pleased to announce that, further to its news release dated January 23, 2024, it has closed a non-brokered private placement (the "Offering") for aggregate gross proceeds of C$3,883,821.90, from the sale of the following:

Each FFT Unit consists of one common share of the Company (each, a “FFT Share”) to be issued as a “flow-through share” within the meaning of the Income Tax Act (Canada) (the “Tax Act”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each SFT Unit consists of one common share of the Company (each, a “SFT Share”) to be issued as a “flow-through share” (as defined in subsection 66(15) of the Tax Act) and one-half of one Warrant. Each Unit consists of one common share of the Company and one-half of one Warrant. Each Warrant shall entitle the holder to purchase one common share of the Company at a price of C$0.36 at any time on or before that date which is 24 months after the closing date of the Offering.

Proceeds from the sale of FFT Shares will be used to incur "Canadian exploration expenses" as defined in subsection 66.1(6) of the Income Tax Act and "flow through critical mineral mining expenditures" as defined in subsection 127(9) of the Income Tax Act. Proceeds from the sale of the SFT Shares will be used to incur “Canadian exploration expenses” that are “flow-through critical mineral mining expenditures” (as such terms are defined in the Tax Act) and “eligible flow-through mining expenditures” (as defined in paragraph 2(2)(b) of The Mineral Exploration Tax Credit Regulations, 2014 (Saskatchewan)). Such proceeds will be renounced to the subscribers with an effective date not later than December 31, 2024, in the aggregate amount of not less than (i) in the case of the FFT Shares, 0.31999 multiplied by the number of FFT Units sold pursuant to the Offering, and (ii) in the case of the SFT Shares, 0.35999 multiplied by the number of SFT Units sold pursuant to the Offering.

The Offered Securities were issued pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the “Listed Issuer Financing Exemption”) and shall be immediately freely tradeable under applicable Canadian securities legislation.

Pursuant to the Offering, the Company has paid a total of $196,696 and issued an aggregate 805,194 finder’s warrants to arm’s-length parties, with each non-transferable finder’s warrant exercisable at any time prior to the date that is 24 months from the closing date to acquire common shares of the Company at an exercise price of C$0.22 per common share. In addition, the Company has paid $100,000 as an advisory fee to Canaccord Genuity Corp.

The Company intends to use the proceeds raised from the Offering for exploration and for general working capital purposes. The Offering is subject to the final approval of the TSX Venture Exchange.

About Stallion Uranium

Stallion Uranium is working to Fuel the Future with Uranium through the exploration of over 3,000 sq/km in the Athabasca Basin, home to the largest high-grade uranium deposits in the world. The company, with JV partner Atha Energy (CSE:SASK), holds the largest contiguous project in the Western Athabasca Basin adjacent to multiple high-grade discovery zones.

Our leadership and advisory teams are comprised of uranium and precious metals exploration experts with the capital markets experience and the technical talent for acquiring and exploring early-stage properties.

Stallion offers optionality with two gold projects in Idaho and Nevada that neighbour world class gold deposits offering exposure to upside potential from district advancement with limited capital expenditures.

For more information visit stallionuranium.com or contact:

Drew Zimmerman

Chief Executive Officer

778-686-0973

info@stallionuranium.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking statements and forward-looking information within the meaning of Canadian securities legislation (collectively, “forward-looking statements”) that relate to the Company’s current expectations and views of future events. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance (often, but not always, through the use of words or phrases such as “will likely result”, “are expected to”, “expects”, “will continue”, “is anticipated”, “anticipates”, “believes”, “estimated”, “intends”, “plans”, “forecast”, “projection”, “strategy”, “objective” and “outlook”) are not historical facts and may be forward-looking statements and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ materially from those expressed in such forward-looking statements. No assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this material change report should not be unduly relied upon. These statements speak only as of the date they are made.

Forward-looking statements are based on a number of assumptions and are subject to a number of risks and uncertainties, many of which are beyond the Company’s control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward-looking statements. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law. New factors emerge from time to time, and it is not possible for the Company to predict all of them, or assess the impact of each such factor or the extent to which any factor, or combination of factors, may cause results to differ materially from those contained in any forward-looking statement. Any forward-looking statements contained in this presentation are expressly qualified in their entirety by this cautionary statement.

Subscribe to our Newsletter